Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Spotlight Interview: Deepinder Dhaliwal

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jan 12th 2023

It was a pleasure to speak with our esteemed Editorial Board Member,  Dr Deepinder Dhaliwal (University of Pittsburgh School of Medicine, Pittsburgh, USA) about her career, research interests and mentors. She also gave us her valuable insight into the biggest developments and challenges in ophthalmology today, and how she sees the field developing in the future.

Questions:

1. Why did you decide to pursue a career in medicine and why, in particular, did you choose to specialise in ophthalmology? (00:38)

2. What are your research interests? (01:50)

3. Who have been your career mentors? (04:04)

4. What has been to most important development in ophthalmology in recent years? (06:30)

5. What have been the biggest challenges in ophthalmology? (07:47)

6. How do you see the field developing? (09:09)

7. What do you enjoy doing outside of work? (10:13)

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup